Reinforce Oral Care With Buccal or Sublingual Buprenorphine

March 2022

A new FDA warning will spur questions about the risk of dental problems with buccal or sublingual buprenorphine (Suboxone, etc).

Labels will now caution about cavities, abscesses, tooth loss, etc. These can happen even in patients withOUT a history of dental problems.

It may be because these products create an acidic environment...which can wear away tooth enamel and lead to decay within weeks or years.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote